Tuning complement activation and pathway through controlled molecular architecture of dextran chains in nanoparticle corona

Archive ouverte

Coty, Jean-Baptiste | Oliveira, Elquio, Eleamen | Vauthier, Christine

Edité par CCSD ; Elsevier -

International audience. The understanding of complement activation by nanomaterials is a key to a rational design of safe and efficient nanomedicines. This work proposed a systematic study investigating how molecular design of nanoparticle coronas made of dextran impacts on mechanisms that trigger complement activation. The nanoparticles used for this work consisted of dextran-coated poly(isobutylcyanoacrylate) (PIBCA) nanoparticles have already been thoroughly characterized. Their different capacity to trigger complement activation established on the cleavage of the protein C3 was also already described making these nanoparticles good models to investigate the relation between the molecular feature of their corona and the mechanism by which they triggered complement activation. Results of this new study shows that complement activation pathways can be selected by distinct architectures formed by dextran chains composing the nanoparticle corona. Assumptions that explain the relation between complement activation mechanisms triggered by the nanoparticles and the nanoparticle corona molecular feature were proposed. These results are of interest to better understand how the design of dextran-coated nanomaterials will impact on interactions with the complement system. It can open perspectives with regard to the selection of a preferential complement activation pathway or prevent the nanoparticles to activate the complement system, based on a rational choice of the corona configuration.

Suggestions

Du même auteur

Characterization of nanomedicines: A reflection on a field under construction needed for clinical translation success

Archive ouverte | Coty, Jean-Baptiste | CCSD

International audience. The nanotechnology revolution offers many expectations for the improvement of medicine treatments. At present, nanomedicine (NM) development is hampered by methodological barriers for a bette...

Nanomedicine characterization for the clinics : development of methods evaluating the interactions nanoparticles-plasmatic proteins for a quality control purpose. Caractérisation des nanomédecines pour la clinique : développement de méthodes évaluant les interactions nanoparticules-protéines plasmatiques pour une application en contrôle qualité

Archive ouverte | Coty, Jean-Baptiste | CCSD

Nanomedicines injected intravenously interact with surrounding biological elements in the bloodstream. Among these interactions, those with blood proteins turn out to be very important regarding the becoming of the nanovectors. Th...

Assessment of Complement Activation by Nanoparticles: Development of a SPR Based Method and Comparison with Current High Throughput Methods

Archive ouverte | Coty, Jean-Baptiste | CCSD

International audience. Purpose: A Surface Plasmon Resonance chip (SPR) was developed to study the activation of complement system triggered by nanomaterials in contact with human serum, which is an important concer...

Chargement des enrichissements...